Literature DB >> 28167981

Macular Involvement and Response to Steroid Therapy Demonstrated by Optical Coherence Tomography in Non-arteritic Anterior Ischaemic Optic Neuropathy.

Sibel Demirel1, Figen Batıoğlu1, Yesim Gedik Oguz1, Emin Özmert1.   

Abstract

Two consecutive patients with anterior non-arteritic ischaemic optic neuropathy were evaluated with spectral-domain optical coherence tomography. The optical coherence tomographic scans revealed subfoveal fluid and intraretinal fluid extending from the optic disc margin toward the fovea that made us think that the submacular fluid appeared to arise from the peripapillary region. Fluorescein angiography showed no accumulation in the macular area, whereas leakage and staining of the optic nerve was present. After systemic corticosteroid therapy, the submacular fluid decreased promptly and the visual acuity improved. Subretinal-fluid-associated disc oedema may develop in some patients with NAION and contribute to the visual loss associated with this condition. Optical coherence tomography should be performed to follow macular involvement in patients with neuro-ophthalmic disease as well as to monitor patients' response to treatment.

Entities:  

Keywords:  Non-arteritic anterior ischaemic optic neuropathy; spectral domain optic coherence tomography; steroid therapy; subretinal fluid

Year:  2013        PMID: 28167981      PMCID: PMC5291070          DOI: 10.3109/01658107.2013.809365

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  9 in total

1.  Optical coherence tomography demonstrates subretinal macular edema from papilledema.

Authors:  V J Hoye; A M Berrocal; T R Hedges; M L Amaro-Quireza
Journal:  Arch Ophthalmol       Date:  2001-09

2.  Treatment of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroid therapy.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-24       Impact factor: 3.117

3.  Peri-Papillary Detachment of the Retina Accompanying Papilledema.

Authors:  A B Reese
Journal:  Trans Am Ophthalmol Soc       Date:  1930

4.  Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-11

Review 5.  Fluids in the anterior part of the optic nerve in health and disease.

Authors:  S S Hayreh
Journal:  Surv Ophthalmol       Date:  1978 Jul-Aug       Impact factor: 6.048

6.  Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-11       Impact factor: 3.117

7.  Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography.

Authors:  Thomas R Hedges; Laurel N Vuong; Alberto O Gonzalez-Garcia; Carlos E Mendoza-Santiesteban; Maria Luz Amaro-Quierza
Journal:  Arch Ophthalmol       Date:  2008-06

8.  Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group.

Authors: 
Journal:  JAMA       Date:  1995-02-22       Impact factor: 56.272

9.  Macular changes resulting from papilloedema.

Authors:  A T Morris; M D Sanders
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

  9 in total
  1 in total

1.  Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy.

Authors:  C Yu; J K Ho; Y J Liao
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.